Empagliflozin in Diuretic Refractory Ascites

Clinical trial NCT05013502 · COMPLETED

Trial details

NCT number: NCT05013502
Sponsor: Stanford University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Liver Cirrhosis Cirrhosis Ascites Ascites Hepatic Sodium-Glucose Transporter 2 Inhibitors

Start date: 2021-11-15
Primary completion: 2023-05-30
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.